Taysha Gene Therapies Inc Revenue per Employee (TSHA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Taysha Gene Therapies Inc   (NASDAQ: TSHA)
 

Taysha Gene Therapies Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Taysha Gene Therapies Inc 's Revenue per employee fell on a trailing twelve month basis to $ 55,404, but the productivity of Taysha Gene Therapies Inc 's employees remained above the company average.
Within the Healthcare sector Taysha Gene Therapies Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Taysha Gene Therapies Inc has 99 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TSHA Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change - - - 171.27 % -
Sales per Employee (TTM) $ 55,404 55,404 75,465 98,717 63,737
TSHA's Total Ranking # # # # 3562 # 3619
Seq. Revenue Change - - - - -

TSHA Company Profile >> Back to TSHA Efficiency Comparisons >> Compare TSHA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 156,071 $ 114,140 $ 72,970
(Dec 31 2023)   (Mar 31 2025)



Financial Statements
Taysha Gene Therapies Inc 's Revenue MRQ $ 0 Millions Visit TSHA's Income Statement
Taysha Gene Therapies Inc 's Revenues TTM $ 5 Millions Visit TSHA's aggregate revenue growth
What are TSHA's Sales? Visit TSHA's Sales by Segment




Other Ratios
Taysha Gene Therapies Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TSHA's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TSHA's Competitors
Revenue per Employee for TSHA's Suppliers
Revenue per Employee for TSHA's Customers

You may also want to know
TSHA's Sales Growth Rates TSHA's Pe Price to earnings ratio TSHA's Receivables Turnover Ratio TSHA's Stock Quote
TSHA's Net Income Growth Rates TSHA's Ps Price to Sales ratio TSHA's Sales per Employee TSHA's Asset Turnover Ratio
TSHA's Net Margin TSHA's Pb Price to Book ratio TSHA's Financial Strength Ratios TSHA's Dividend Payout Ratio
Date modified: 2026-11-13T08:46:31+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Sonoma Pharmaceuticals Inc   93,960.00 $ 23.490  Million 250 
Aclaris Therapeutics Inc   87,684.93 $ 6.401  Million 73 
Biomerica Inc   86,760.00 $ 4.338  Million 50 
Teleflex Incorporated  82,817.74 $ 1,283.675  Million 15,500 
Lenz Therapeutics Inc   81,309.21 $ 12.359  Million 152 
Metagenomi Therapeutics Inc   59,546.22 $ 7.086  Million 119 
Healthcare Services Group Inc   52,218.33 $ 1,879.860  Million 36,000 
Upstream Bio Inc   38,266.67 $ 2.870  Million 75 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.